[1]	Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025[J]. CA Cancer J Clin, 2025, 75(1): 10-45. DOI: 10.3322/caac.21871. 本文引用 [1]

[2]	Spronk I, Schellevis FG, Burgers JS, et al. Incidence of isolated local breast cancer recurrence and contralateral breast cancer: A systematic review[J]. Breast, 2018, 39(6): 70-79. DOI: 10.1016/j.breast.2018.03.011. 本文引用 [1]

[3]	Cardoso F, Castiglione M, Group EGW. Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up[J]. Ann Oncol, 2009, 20(4): 15-18. DOI: 10.1093/annonc/mdp115. 本文引用 [1]

[4]	Dinh P, Cardoso F, Sotiriou C, et al. New tools for assessing breast cancer recurrence[J]. Cancer Treat Res, 2008, 141: 99-118. DOI: 10.1007/978-0-387-73161-2_7. 本文引用 [1]

[5]	中国抗癌协会乳腺癌专业委员会, 中华医学会肿瘤学分会乳腺肿瘤学组. 中国抗癌协会乳腺癌诊治指南与规范(2024年版)[J]. 中国癌症杂志, 2023, 33 (12): 1092-1187. DOI: 10.19401/j.cnki.1007-3639.2023.12.004. 本文引用 [17]

[6]	Ma JF, Chen LY, Wu SL, et al. Clinical practice guidelines for ultrasound-guided breast lesions and lymph nodes biopsy: Chinese society of breast surgery (CSBrS) practice guidelines 2021[J]. Chin Med J (Engl), 2021, 134(12): 1393-1395. DOI: 10.1097/CM9.0000000000001549. 本文引用 [5]

[7]	Gradishar WJ, Moran MS, Abraham J, et al. Breast Cancer, Version 3.2024, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2024, 22(5): 331-357. DOI: 10.6004/jnccn.2024.0035. 本文引用 [18]

[8]	Yin W, Di G, Zhou L, et al. Time-varying pattern of recurrence risk for Chinese breast cancer patients[J]. Breast Cancer Res Treat, 2009, 114(3): 527-535. DOI: 10.1007/s10549-008-0022-5. 本文引用 [1]

[9]	Demicheli R, Abbattista A, Miceli R, et al. Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy[J]. Breast Cancer Res Treat, 1996, 41(2): 177-185. DOI: 10.1007/BF01807163. 本文引用 [1]

[10]	Fowble B. Ipsilateral breast tumor recurrence following breast-conserving surgery for early-stage invasive cancer[J]. Acta Oncol, 1999, 38(13): 9-17. DOI: 10.1080/028418699432716. 本文引用 [1]

[11]

Sasson AR, Fowble B, Hanlon AL, et al. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation[J]. Cancer, 2001, 91(10): 1862-1869. DOI: 10.1002/1097-0142(20010515)91:10<1862::aid-cncr1207>3.0.co;2-#. 本文引用 [1]

[12]	Cardoso F, Paluch-Shimon S, Senkus E, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)[J]. Ann Oncol, 2020, 31(12):1623-1649. DOI: 10.1016/j.annonc.2020.09.010. 本文引用 [1]

[13]	Rong J, Wang S, Ding Q, et al. Comparison of 18FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis[J]. Surg Oncol, 2013, 22(2): 86-91. DOI: 10.1016/j.suronc.2013.01.002. 本文引用 [1]

[14]	Groheux D, Cochet A, Humbert O, et al. 18F-FDG PET/CT for staging and restaging of breast cancer[J]. J Nucl Med, 2016, 57(1): 17S-26S. DOI: 10.2967/jnumed.115.157859. 本文引用 [1]

[15]	Groheux D, Hindie E, Marty M, et al. 18F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer[J]. Eur J Radiol, 2014, 83(10): 1925-1933. DOI: 10.1016/j.ejrad.2014.05.037. 本文引用 [1]

[16]	Veit-Haibach P, Antoch G, Beyer T, et al. FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy[J]. Br J Radiol, 2007, 80(955): 508-515. DOI: 10.1259/bjr/17395663. 本文引用 [1]

[17]

Demicheli R, Ardoino I, Boracchi P, et al. Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast[J]. BMC Cancer, 2010, 10: 656-664. DOI: 10.1186/1471-2407-10-656. 本文引用 [1]

[18]	De Hert S, Staender S, Fritsch G, et al. Pre-operative evaluation of adults undergoing elective noncardiac surgery: Updated guideline from the European Society of Anaesthesiology[J]. Eur J Anaesthesiol, 2018, 35(6): 407-465. DOI: 10.1097/EJA.0000000000000817. 本文引用 [1]

[19]

Walstra C, Schipper RJ, van Riet YE, et al. Repeat breast-conserving treatment of ipsilateral breast cancer recurrence: a nationwide survey amongst breast surgeons and radiation oncologists in the Netherlands[J]. Breast Cancer Res Treat, 2021, 187(2): 499-514. DOI: 10.1007/s10549-021-06154-2. 本文引用 [1]

[20]	Walstra C, Schipper RJ, Poodt IGM, et al. Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: A systematic review[J]. Eur J Surg Oncol, 2019, 45(8): 1317-1327. DOI: 10.1016/j.ejso.2019.02.008. 本文引用 [1]

[21]

Arthur DW, Winter KA, Kuerer HM, et al. Effectiveness of breast-conserving surgery and 3-dimensional conformal partial breast reirradiation for recurrence of breast cancer in the ipsilateral breast: The NRG Oncology/RTOG 1014 phase 2 clinical trial[J]. JAMA Oncol, 2020, 6(1): 75-82. DOI: 10.1001/jamaoncol.2019.4320. 本文引用 [1]

[22]	ElSherif A, Shah C, Downs-Kelly E, et al. Outcomes of ipsilateral breast tumor recurrence after breast conserving surgery: Repeat lumpectomy as an alternative to salvage mastectomy[J]. Surgery, 2022, 171(3): 673-681. DOI: 10.1016/j.surg.2021.10.069. 本文引用 [1]

[23]

Alpert TE, Kuerer HM, Arthur DW, et al. Ipsilateral breast tumor recurrence after breast conservation therapy: Outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation[J]. Int J Radiat Oncol Biol Phys, 2005, 63(3): 845-851. DOI: 10.1016/j.ijrobp.2005.02.035. 本文引用 [1]

[24]	Headon HL, Kasem A, Mokbel K. The oncological safety of nipple-sparing mastectomy: A systematic review of the literature with a pooled analysis of 12,358 procedures[J]. Arch Plast Surg, 2016, 43(4):328-338. DOI: 10.5999/aps.2016.43.4.328. 本文引用 [1]

[25]	Hannoun-Levi JM, Houvenaeghel G, Ellis S, et al. Partial breast irradiation as second conservative treatment for local breast cancer recurrence[J]. Int J Radiat Oncol Biol Phys, 2004, 60(5): 1385-1392. DOI: 10.1016/j.ijrobp.2004.05.035. 本文引用 [1]

[26]	Halverson KJ, Perez CA, Kuske RR, et al. Locoregional recurrence of breast cancer: A retrospective comparison of irradiation alone versus irradiation and systemic therapy[J]. Am J Clin Oncol, 1992, 15(2): 93-101 本文引用 [1]

[27]

Hannoun-Levi JM, Resch A, Gal J, et al. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: Multicentric study of the GEC-ESTRO Breast Cancer Working Group[J]. Radiother Oncol, 2013, 108(2): 226-231. DOI:10.1016/j.radonc.2013.03.026. 本文引用 [1]

[28]	Newman LA, Hunt KK, Buchholz T, et al. Presentation, management and outcome of axillary recurrence from breast cancer[J]. Am J Surg, 2000, 180(4): 252-256. DOI: 10.1016/s0002-9610(00)00456-6. 本文引用 [3]

[29]	de Boer R, Hillen HF, Roumen RM, et al. Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer[J]. Br J Surg, 2001, 88(1): 118-122. DOI: 10.1046/j.1365-2168.2001.01637.x. 本文引用 [2]

[30]	Bulte JP, van Wely BJ, Kasper S, et al. Long-term follow-up of axillary recurrences after negative sentinel lymph node biopsy: Effect on prognosis and survival[J]. Breast Cancer Res Treat, 2013, 140(1): 143-149. DOI: 10.1007/s10549-013-2608-9. 本文引用 [3]

[31]	Konkin DE, Tyldesley S, Kennecke H, et al. Management and outcomes of isolated axillary node recurrence in breast cancer[J]. Arch Surg, 2006, 141(9): 867-874. DOI: 10.1001/archsurg.141.9.867. 本文引用 [1]

[32]	Pedersen AN, Moller S, Steffensen KD, et al. Supraclavicular recurrence after early breast cancer: A curable condition?[J]. Breast Cancer Res Treat, 2011, 125(3): 815-822. DOI: 10.1007/s10549-010-0918-8. 本文引用 [3]

[33]	Chen SC, Chang HK, Lin YC, et al. Prognosis of breast cancer after supraclavicular lymph node metastasis: Not a distant metastasis[J]. Ann Surg Oncol, 2006, 13(11): 1457-1465. DOI: 10.1245/s10434-006-9012-1.

[34]

Brito RA, Valero V, Buzdar AU, et al. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience[J]. J Clin Oncol, 2001, 19(3): 628-633. DOI: 10.1200/JCO.2001.19.3.628. 本文引用 [1]

[35]	Chu FC, Lin FJ, Kim JH, et al. Locally recurrent carcinoma of the breast. Results of radiation therapy[J]. Cancer, 1976, 37(6): 2677-2681. DOI: 10.1002/1097-0142(197606)37:6<2677::aid-cncr2820370616>3.0.co;2-l. 本文引用 [1]

[36]	Jackson SM. Carcinoma of the breast--the significance of supraclavicular lymph node metastases[J]. Clin Radiol, 1966, 17(2): 107-114. DOI: 10.1016/s0009-9260(66)80066-1. 本文引用 [1]

[37]	Willner J, Kiricuta I, Kolbl O, et al. Supraclavicular lymph-node recurrence of breast-cancer[J]. Oncol Rep, 1994, 1(6): 1235-1245. DOI: 10.3892/or.1.6.1235. 本文引用 [1]

[38]	Fentiman IS, Lavelle MA, Caplan D, et al. The significance of supraclavicular fossa node recurrence after radical mastectomy[J]. Cancer, 1986, 57(5): 908-910. DOI: 10.1002/1097-0142(19860301)57:5<908::aid-cncr2820570504>3.0.co;2-q. 本文引用 [1]

[39]	Tang P, Hu Y, Wang ZH, et al. Clinical practice guidelines for endoscopic breast surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021[J]. Chin Med J (Engl), 2021, 134(21): 2532-2534. DOI: 10.1097/CM9.0000000000001592. 本文引用 [1]

[40]	Gibbs NM. Venous thrombosis of the lower limbs with particular reference to bed-rest[J]. Br J Surg, 1957, 45(191): 209-236. DOI: 10.1002/bjs.18004519102. 本文引用 [1]